Loading organizations...
Rock Maple Ventures operates as a venture capital firm providing capital, resources, and strategic expertise to early-stage technology and healthcare companies. The firm targets innovation across software, artificial intelligence, digital transformation, biotechnology, medical devices, and digital health platforms. Its hands-on approach empowers portfolio companies through dedicated support and industry connections.
Established in 2001 by David W. Freelove, Rock Maple Ventures was founded on the insight that larger venture funds often overlooked promising low-capital, high-growth enterprises. Freelove created the firm to fund early-revenue businesses, guiding them through critical growth phases towards profitable exits for all parties, addressing a crucial void in venture funding.
The firm primarily supports visionary entrepreneurs and early-stage startups in technology and healthcare. Rock Maple Ventures' mission is to enable portfolio companies to scale efficiently and achieve market potential. They aim to drive progress and cultivate lasting value by investing in nascent innovations, fostering a future where transformative ideas become impactful businesses.
Rock Maple Ventures has 1 tracked investment across 1 company. The latest tracked deal is $5.0M Series D in Seahorse Bioscience in March 2010.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 1, 2010 | Seahorse Bioscience | $5.0M Series D | — | EQT Life Sciences, Commonwealth Capital Ventures, FLIR Systems, HealthCare Ventures, HLM Venture Partners, LSP, Oxford Bioscience Partners |